Olema Pharmaceuticals Statistics
Total Valuation
OLMA has a market cap or net worth of $1.30 billion. The enterprise value is $802.62 million.
Important Dates
The last earnings date was Monday, March 16, 2026, before market open.
| Earnings Date | Mar 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OLMA has 87.16 million shares outstanding. The number of shares has increased by 48.11% in one year.
| Current Share Class | 87.16M |
| Shares Outstanding | 87.16M |
| Shares Change (YoY) | +48.11% |
| Shares Change (QoQ) | +6.51% |
| Owned by Insiders (%) | 2.79% |
| Owned by Institutions (%) | 87.73% |
| Float | 71.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.54 |
| P/TBV Ratio | 2.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.95, with a Debt / Equity ratio of 0.01.
| Current Ratio | 9.95 |
| Quick Ratio | 9.84 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.61% and return on invested capital (ROIC) is -23.61%.
| Return on Equity (ROE) | -36.61% |
| Return on Assets (ROA) | -21.42% |
| Return on Invested Capital (ROIC) | -23.61% |
| Return on Capital Employed (ROCE) | -35.03% |
| Weighted Average Cost of Capital (WACC) | 15.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.24M |
| Employee Count | 131 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +261.35% in the last 52 weeks. The beta is 2.02, so OLMA's price volatility has been higher than the market average.
| Beta (5Y) | 2.02 |
| 52-Week Price Change | +261.35% |
| 50-Day Moving Average | 23.41 |
| 200-Day Moving Average | 14.25 |
| Relative Strength Index (RSI) | 29.18 |
| Average Volume (20 Days) | 2,117,031 |
Short Selling Information
The latest short interest is 8.26 million, so 9.47% of the outstanding shares have been sold short.
| Short Interest | 8.26M |
| Short Previous Month | 9.00M |
| Short % of Shares Out | 9.47% |
| Short % of Float | 11.49% |
| Short Ratio (days to cover) | 6.13 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -168.70M |
| Pretax Income | -162.45M |
| Net Income | -162.45M |
| EBITDA | -168.21M |
| EBIT | -168.70M |
| Earnings Per Share (EPS) | -$1.87 |
Full Income Statement Balance Sheet
The company has $505.44 million in cash and $4.19 million in debt, with a net cash position of $501.24 million or $5.75 per share.
| Cash & Cash Equivalents | 505.44M |
| Total Debt | 4.19M |
| Net Cash | 501.24M |
| Net Cash Per Share | $5.75 |
| Equity (Book Value) | 478.56M |
| Book Value Per Share | 5.88 |
| Working Capital | 463.65M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -146.72M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 490,000 |
| Net Borrowing | 3.00M |
| Free Cash Flow | -146.72M |
| FCF Per Share | -$1.68 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OLMA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -48.11% |
| Shareholder Yield | -48.11% |
| Earnings Yield | -12.46% |
| FCF Yield | -11.25% |
Analyst Forecast
The average price target for OLMA is $44.89, which is 200.07% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $44.89 |
| Price Target Difference | 200.07% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -3.46% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |